27 related articles for article (PubMed ID: 10698268)
1. Crystal structure of the tyrosine kinase domain of the human insulin receptor.
Hubbard SR; Wei L; Ellis L; Hendrickson WA
Nature; 1994 Dec 22-29; 372(6508):746-54. PubMed ID: 7997262
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases.
Bell IM; Stirdivant SM; Ahern J; Culberson JC; Darke PL; Dinsmore CJ; Drakas RA; Gallicchio SN; Graham SL; Heimbrook DC; Hall DL; Hua J; Kett NR; Kim AS; Kornienko M; Kuo LC; Munshi SK; Quigley AG; Reid JC; Trotter BW; Waxman LH; Williams TM; Zartman CB
Biochemistry; 2005 Jul; 44(27):9430-40. PubMed ID: 15996097
[TBL] [Abstract][Full Text] [Related]
3. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
Glover NR; Tracey AS
Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
[TBL] [Abstract][Full Text] [Related]
4. Modelling of active forms of protein kinases: p38--a case study.
Ginalski K; Lesyng B; Sowadski J; Wojciechowski M
Acta Biochim Pol; 1997; 44(3):557-64. PubMed ID: 9511965
[TBL] [Abstract][Full Text] [Related]
5. Modelling of insulin receptor tyrosine kinase in its active form: a case study for validation of theoretical methods.
Ginalski K; Wojciechowski M; Lesyng B
Acta Biochim Pol; 1999; 46(3):601-7. PubMed ID: 10698268
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase-substrate interactions.
Bose R; Holbert MA; Pickin KA; Cole PA
Curr Opin Struct Biol; 2006 Dec; 16(6):668-75. PubMed ID: 17085043
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase inhibitors: insights into drug design from structure.
Noble ME; Endicott JA; Johnson LN
Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
[TBL] [Abstract][Full Text] [Related]
8. How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase.
Taylor SS; Radzio-Andzelm E; Hunter T
FASEB J; 1995 Oct; 9(13):1255-66. PubMed ID: 7557015
[TBL] [Abstract][Full Text] [Related]
9. The first structure of a receptor tyrosine kinase domain: a further step in understanding the molecular basis of insulin action.
McDonald NQ; Murray-Rust J; Blundell TL
Structure; 1995 Jan; 3(1):1-6. PubMed ID: 7743124
[TBL] [Abstract][Full Text] [Related]
10. [The Apollinaire Bouchardat Prize 1993. Structural organization and molecular dissection of the functions of the insulin receptor].
Clauser E
Journ Annu Diabetol Hotel Dieu; 1993; ():63-80. PubMed ID: 8392643
[No Abstract] [Full Text] [Related]
11. Protein kinases--structure and function.
Bossemeyer D
FEBS Lett; 1995 Aug; 369(1):57-61. PubMed ID: 7641885
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
